Navigation Links


Interim at Biology News

Interim at Biology Products
Interim at Biology Technology
Interim at Medicine News

Bruce Vladeck Will Hold Fort (interim) of UMDNJ

Bruce C. Vladeck, an expert in health care policy, is slated to be the interim president of the University of Medicine and Dentistry at New Jersey. Vladeck in an earlier capacity had been in charge of the federal Medicaid and Medicare programs. // Vladeck will now replace UMDNJ president John Petillo, who was eased out of his chair by Gov. Jon Corzine. The Formal relinquishing of author...

Interim WHO Chief Confirms 'No radical changes' in WHO

Geneva - The new interim head of the World Health Organization (WHO), Dr Anders Nordstrom, addressing the press for the first time since assuming office // , confirmed that Dr Anders Nordstrom. He also emphasized the need for additional financial resources and the support from the people to continue the fight against HIV/Aids, malaria and polio. He reiterated that he would continue th...

Interim OPD saves the day for patients

Medical college and hospital was a scene of pandemonium with protesting students on the one side and junior doctors initiating an outpatients’ department// on the other, causing apparent commotion amongst patients. The groups, under the name of ‘Youth for equality’ are behind these protests. Patients have expressed consolation at the opening of the parallel OPD. A patient Bimal Chandra...
Interim at Medicine Products

Interim Mobile Cardiac Catheterization and Angiography Services

Description:MedCath Diagnostics currently maintains a large number of mobile, modular and transportable cath and vascular labs in its rental fleet. The labs are typically leased to hospitals for several months to several years. The Cath Lab Leasing Company allows hospitals to quickly add capacity while replacing or upgrading existing equipment, initiating a new service and undergoing seasonal volume fluctuat...
Company:MedCath Corporation
Interim at Medicine Technology

Cell Therapeutics, Inc. Management to Discuss Today's Announcement of Interim Pixantrone Study Results

SEATTLE, July 11, 2007 /PRNewswire-FirstCall/ -- On Wednesday,July 11, 2007, at 1:30 p.m. Pacific/4:30 p.m. Eastern/10:30 p.m.Central European Time members of Cell Therapeutics, Inc.'s (CTI)management team will host a conference call to discuss today'sannouncement of the interim results of its phase II/III RAPID trialcomparing CHOP-R to CPOP-R, in which pixantrone is substituted fordoxor...

Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology

LUGANO, Switzerland--(BUSINESS WIRE)--Jul 9, 2007 - ZIOPHARMOncology, Inc. (NASDAQ: ZIOP) announces that positive interim datafrom an ongoing phase II trial of ZIO-201 (isophosphoramide mustard- IPM) to treat advanced sarcoma patients was presented at theEuropean Society of Medical Oncology (ESMO) meeting held July 5-8,2007 in Lugano, Switzerland. The abstract entitled, "Phase-I/IIStudy of...

Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)

GHENT, Belgium, 2 July, 2007 -- Ablynx today announced positiveinterim results from the ongoing Phase I study of its leaddevelopment programme, ALX-0081, an anti-thrombotic treatment.ALX-0081 is a novel ´first-in-class´ therapeuticNanobody® targeting von Willebrand Factor (vWF), which canreduce the risk of thrombosis in patients with acute coronarysyndrome. The Pha...

Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma

WORCESTER, Mass.--(BUSINESS WIRE)--Jun 28, 2007 - BiovestInternational, Inc. (OTCBB: BVTI), a majority owned subsidiary ofAccentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), announced on June27, 2007 blinded interim data from the start of its fast-trackedpivotal Phase 3 clinical trial of BiovaxID(TM) for Non-Hodgkin'slymphoma (NHL) from September 2000 through June 2006. This interimblinded dat...

ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop

KOS, Greece--(BUSINESS WIRE)--Jun 28, 2007 - ZIOPHARM Oncology,Inc. (NASDAQ: ZIOP), announced today the presentation of twoposters at the XIth Annual International Myeloma Workshop beingheld in Kos, Greece from June 25-28th, 2007. The meeting highlightsimportant advances made in the biology and treatment of multiplemyeloma. ZIOPHARM is presenting darinaparsin (ZIO-101) geneexpression profil...

More>>

Other TagsXDRAdhereCaffei
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2
(Date:7/25/2008)... born with hydrocephalus, or "water on the brain" ... from the brain to reduce harmful pressure. , W...nfection in children is very high for a variety of... another surgery to replace the shunt, bringing wi...rological complications and an increased risk of d...
(Date:7/25/2008)...ew research published in the July issue of the Jo...levated plasma DNA is a reliable marker of recurre... plasma DNA levels rise before clinical evidence o... , Esophageal cancer, one of the leading causes ... a late stage. An accurate marker for detecting es...
(Date:7/24/2008)...d growing demand for bio-fuels and hydro-electrici...reatest threats today to the preservation of preci...ook for new areas for agriculture, energy crop pla...essures to convert wetlands is vital to avoid dest... essential to humanity, including safe, steady loc...
(Date:7/24/2008)...up plants just as they do human athletes, but the ...to boost growth and development in plant cells is ...s. A new study by plant biologists at the Carnegie...alled proteomics to identify key links in the ster... hormones activate genes could lead not only to en...
Breaking Biology News(10 mins):Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds 2Rising energy, food prices major threats to wetlands as farmers eye new areas for crops 2Rising energy, food prices major threats to wetlands as farmers eye new areas for crops 3Plant steroids offer new paradigm for how hormones work 2Plant steroids offer new paradigm for how hormones work 3AIDS Vaccine Failures Highlight Need to Focus on Lifesaving Treatment Says AHF 6473 1AIDS Vaccine Failures Highlight Need to Focus on Lifesaving Treatment Says AHF 6473 2Award Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec 1 for 24 hour Vigil Recognizing World AIDS Day 867 1Award Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec 1 for 24 hour Vigil Recognizing World AIDS Day 867 2Award Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec 1 for 24 hour Vigil Recognizing World AIDS Day 867 3Award Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec 1 for 24 hour Vigil Recognizing World AIDS Day 867 4Two faced miniatures 1836 1Two faced miniatures 1836 2NightHawk Radiology 3A One Source One Solution 6465 1NightHawk Radiology 3A One Source One Solution 6465 2NightHawk Radiology 3A One Source One Solution 6465 3NightHawk Radiology 3A One Source One Solution 6465 4
Other Contentstranslationtranslationtranslationtranslationtranslationtranslationtranslationtransfectiontransfectiontransfectiontransienttransienttransienttransienttransienttransienttranslocationtranslocationtranslocationtranslocationtranslocationtranslocationproteinsproteinsproteinsproteinsproteinsproteinsproteinsproteinsproteinselementelementelementelementelementelementelementelementelementtransposabletransposabletransposase